cystic fibrosis transmembrane conductance regulator (505-511) has been researched along with Cystic Fibrosis of Pancreas in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 9 (64.29) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bompadre, SG; Kopeikin, Z; Yang, HY; Yuksek, Z | 1 |
Mayor, S | 1 |
Ittenbach, RF; McBride, MG; Paridon, SM; Schall, JI; Stallings, VA; Zemel, BS | 1 |
Cooper-Knock, J; Garrard, K; Lo, C; Martindale, J; Shaw, P; Williams, T | 1 |
Banks-Schlegel, SP; Guggino, WB | 1 |
Aebischer, CC; Keller, BM; Kraemer, R; Schöni, MH | 1 |
Cabello, GM; Cabello, PH; Fernandes, O; Llerena, JC; Lopez-Camelo, JS | 1 |
Nau, JY | 1 |
Ratjen, F | 1 |
Ahrens, RC; Aitken, ML; Hilliard, KA; Kelley, TJ; Konstan, MW; Launspach, J; McCarty, NA; Milgram, LJ; Regelmann, WE; Standaert, TA; Teresi, M; Tuthill, C; Weatherly, MR | 1 |
Brooks, JG; Detzer, M; Kahn, R; Lever, T; Maddock, J; O'Connor, GT; Quinton, HB; Robichaud, P | 1 |
Bush, A; Crowley, S | 1 |
Borowitz, D; Cimino, M; Simon, D | 1 |
Chan, HC; Dedman, JR; Hazarika, P; Kaetzel, MA; Nelson, DJ | 1 |
2 review(s) available for cystic fibrosis transmembrane conductance regulator (505-511) and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Macromolecular interactions and ion transport in cystic fibrosis.
Topics: Cell Membrane; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Forecasting; Humans; Ion Transport; Macromolecular Substances; Mutation; Needs Assessment; Peptide Fragments; Protein Folding; Protein Interaction Mapping; Research | 2004 |
New pulmonary therapies for cystic fibrosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lung Diseases; Peptide Fragments; Sodium Channel Blockers; Treatment Outcome | 2007 |
1 trial(s) available for cystic fibrosis transmembrane conductance regulator (505-511) and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
A phase I randomized, multicenter trial of CPX in adult subjects with mild cystic fibrosis.
Topics: Adolescent; Adult; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dose-Response Relationship, Drug; Female; Humans; Male; Membrane Potentials; Mutation, Missense; Nasal Mucosa; Peptide Fragments; Purinergic P1 Receptor Antagonists; Regression Analysis; Research Design; Sweat; Treatment Outcome; Xanthines | 2002 |
11 other study(ies) available for cystic fibrosis transmembrane conductance regulator (505-511) and Cystic Fibrosis of Pancreas
Article | Year |
---|---|
Combined effects of VX-770 and VX-809 on several functional abnormalities of F508del-CFTR channels.
Topics: Adenosine Triphosphate; Aminophenols; Aminopyridines; Benzodioxoles; Carrier Proteins; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Patch-Clamp Techniques; Peptide Fragments; Quinolones | 2014 |
Drug combination that corrects deficient protein in cystic fibrosis improves lung function.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Therapy, Combination; Humans; Peptide Fragments; Quinolones; Randomized Controlled Trials as Topic; Respiratory Function Tests | 2015 |
Clinical and genetic correlates of exercise performance in young children with cystic fibrosis.
Topics: Anthropometry; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Exercise Test; Female; Genotype; Heterozygote; Humans; Male; Malnutrition; Nutritional Status; Peptide Fragments; Respiratory Function Tests | 2010 |
Concurrent amyotrophic lateral sclerosis and cystic fibrosis supports common pathways of pathogenesis.
Topics: Adult; Amyotrophic Lateral Sclerosis; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA-Binding Proteins; Female; Humans; Mutation; Peptide Fragments; RNA Splicing | 2013 |
Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
Topics: Adolescent; Analysis of Variance; Body Height; Body Mass Index; Body Weight; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Forced Expiratory Volume; Genotype; Growth Disorders; Homozygote; Hospitals, Pediatric; Humans; Linear Models; Longitudinal Studies; Male; Maximal Midexpiratory Flow Rate; Mutation; Peptide Fragments; Retrospective Studies; Switzerland; Vital Capacity | 2003 |
Haplotype distribution of and linkage disequilibrium between four polymorphic markers near the CFTR locus in Brazilian cystic fibrosis patients.
Topics: Africa South of the Sahara; Alleles; Brazil; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Genetics, Population; Haplotypes; Humans; Linkage Disequilibrium; Mediterranean Islands; Peptide Fragments; Polymorphism, Genetic | 2005 |
[Prenatal testing for cystic fibrosis].
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Mutation; Peptide Fragments; Pregnancy; Prenatal Diagnosis | 2006 |
Case-mix adjustment for evaluation of mortality in cystic fibrosis.
Topics: Age Factors; Child; Child, Preschool; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Ethnicity; Female; Genotype; Humans; Infant; Male; Multivariate Analysis; Peptide Fragments; Proportional Hazards Models; Racial Groups; Registries; Risk Adjustment; Sex Factors; Socioeconomic Factors; Survival Analysis; United States | 2002 |
Cystic fibrosis: keeping it in the family.
Topics: Adult; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Fertility; Homozygote; Humans; Infant; Male; Peptide Fragments; Phenotype; Pregnancy; Sweat | 2002 |
Normal volume of distribution of tobramycin in a mother and daughter with a CFTR splice mutation (1717 - 1G --> A).
Topics: Adult; Anti-Bacterial Agents; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Mutation; Peptide Fragments; Tobramycin | 2002 |
Antibody against a cystic fibrosis transmembrane conductance regulator-derived synthetic peptide inhibits anion currents in human colonic cell line T84.
Topics: Anions; Antibodies; Biological Transport; Blotting, Western; Calcium; Cations, Divalent; Cell Line; Chlorides; Colon; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diffusion; Humans; Membrane Proteins; Oligopeptides; Peptide Fragments; Peptides | 1992 |